ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGY Allergy Therapeutics Plc

3.00
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics Plc LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.00 2.80 3.20 3.00 3.00 3.00 32,599 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 59.59M -43.07M -0.0090 -3.33 142.99M
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 3p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 0.85p to 3.80p.

Allergy Therapeutics currently has 4,766,439,938 shares in issue. The market capitalisation of Allergy Therapeutics is £142.99 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -3.33.

Allergy Therapeutics Share Discussion Threads

Showing 3451 to 3475 of 5000 messages
Chat Pages: Latest  140  139  138  137  136  135  134  133  132  131  130  129  Older
DateSubjectAuthorDiscuss
03/11/2017
11:08
Jimmy, Are you able to post Panmure statement or a link to it
richsawko
03/11/2017
10:09
Ewanwhose et al,
Panmure have issued an exceptional research note on AGY.
The price target is 53p including 12p of USA though they add with the portfolio and multiple news catalysts that 'anything could happen'

DYOR

jimmyloser
01/11/2017
09:26
Looks like a nice spot to buy for the next leg up. So I have.
volsung
01/11/2017
08:09
I would say that now is less risky than the past as the pipeline has advanced successfully. Going forward my be cautious but potential rewards outstanding
richsawko
31/10/2017
22:50
Just got some spare cash after several years. Was in these a long time ago but the story still seems as it was.Still like the concept but is there any reason to get now?
ewanwhose
24/10/2017
15:21
There is smoke here today and you know what they say...impo.
jimmyloser
24/10/2017
11:24
There's always another buying opp. They're like buses.
volsung
24/10/2017
11:08
Buying opportunity gone!
audigger
23/10/2017
08:08
Whilst they may need cash in the future, I'm not seeing the need to raise any now. It does raise the interesting question as to what price would a rights issue be at?
audigger
22/10/2017
09:44
3335 - you bet!

That wasn't the market impo, it was just a correction caused by panic amongst small fry.

It was frothy.

impo/dyor

jimmyloser
22/10/2017
09:37
AuDigger & volsung - or the market sees a rights issue coming if the special resolutions are passed at next month's AGM?
b1lbo
20/10/2017
15:45
certainly looks that way
volsung
20/10/2017
15:43
Strange that its taken such a big hit today. Buying opportunity!
audigger
13/10/2017
10:30
Would love to think this is now going to go after so many years, but hey, we've been here before!
aruntim
13/10/2017
08:17
Well bought some more this morning
volsung
12/10/2017
19:15
I'd be happy to sell at 100p in 3-4years time. I originally bought at 7p and sold almost immediately at 14p on news that the clinical hold was lifted. Since then I have bought at 14p, 18p, 25p and 32p. I have a paper profit but see this as a medium term play that should come to fruition if they are successful,in the USA. Thereafter their novel adjuvant systems and potential to address peanut allergy represents further potential upside. And.....one should not forget the EU business which continues to grow market share. That's why I'm thinking beyond 60p. Knowing at what point to sell when you're in profit is one of the hardest investment decisions!
audigger
12/10/2017
16:48
That was a long time ago. I don't like to tempt fate!
jimmyloser
12/10/2017
16:32
If you weren't called jimmyloser I'd be encouraged by that post
volsung
12/10/2017
16:30
It has surprised me on the upside. I have this to be 35p by year end in my forecast. It has murdered that.
I would say that the dynamics at play here are
>That the market is starting to forget the American setback.
>The strength of performance with added consistency.
> The strategy and management have credibility
> The portfolio is strong and coming to fruition is some cases.
>They are 100% on a charm offensive

SOLID/RELIABLE AND WITH HUGE UPSIDE POTENTIAL

impo/dyor

I am now seeking 55p by the end of next year. Fingers crossed.

jimmyloser
12/10/2017
16:08
I've had this stock since 2009, we've always said it was a slow burn, I don't think I realised how slow. I have a sell set from 60p in small parcels up to 90p, what others thoughts on this?
aruntim
12/10/2017
16:01
Non-exec buying shares
aruntim
10/10/2017
19:19
We appear to have a breakout situation! The company are spreading the word and people are waking up to the potential.
audigger
10/10/2017
06:46
Today’s RNS released by AGY featuring Hardman and Cos paper would be a good reason. Not showing above in News re RNS as I post. Company sponsored but very positive appraisal.
friendzarin
09/10/2017
16:00
wow - this is going well.

Any thoughts as to why this is flying?

stefanj26
09/10/2017
14:29
See Link to slides from Thursday nights presentation given by Nick Wykeman (CFO)


I made a few brief notes (mainly from the Q&As) so I will endeavor to write those up this evening

timbo003
Chat Pages: Latest  140  139  138  137  136  135  134  133  132  131  130  129  Older

Your Recent History

Delayed Upgrade Clock